1,4-dihydropyridine has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuccaro, ML; Jacobs, LS; Lorenson, MY | 1 |
| Aygün Cevher, H; Çelebier, M; Gambeta, E; Gandini, MA; Gündüz, MG; Kaplan, O; Schaller, D; Tahir, MN; Wolber, G; Zamponi, GW; Zhang, FX | 1 |
2 other study(ies) available for 1,4-dihydropyridine and cysteine
| Article | Year |
|---|---|
Calcium release from pituitary secretory granules: modulation by thiols, disulfides, and dihydropyridine calcium channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Cattle; Cysteine; Cystine; Cytoplasmic Granules; Dihydropyridines; Disulfides; Dithiothreitol; Glutathione; Hydrogen-Ion Concentration; Mercaptoethanol; Nifedipine; Nimodipine; Pituitary Gland; Potassium Chloride; Sulfhydryl Compounds | 1990 |
Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels.
Topics: Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cysteine; Dihydropyridines; Drug Discovery; Glutathione; Humans; Models, Molecular; Protein Conformation | 2019 |